Dunrui Wang

964 total citations
32 papers, 631 citations indexed

About

Dunrui Wang is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Dunrui Wang has authored 32 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Cell Biology and 7 papers in Cancer Research. Recurrent topics in Dunrui Wang's work include Ubiquitin and proteasome pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Dunrui Wang is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Dunrui Wang collaborates with scholars based in United States, Japan and Malaysia. Dunrui Wang's co-authors include Xiaolan Qian, Douglas R. Lowy, Edward K. L. Chan, Jill P. Buyon, Brajendra K. Tripathi, Marian E. Durkin, Wei‐Guo Zhu, Alex G. Papageorge, Giovanna Tosato and Yi‐Chieh Nancy Du and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Dunrui Wang

30 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dunrui Wang United States 17 419 155 143 121 101 32 631
Morihiro Higo Japan 18 584 1.4× 254 1.6× 142 1.0× 228 1.9× 99 1.0× 36 841
Dong L. Barraclough United Kingdom 10 419 1.0× 149 1.0× 254 1.8× 150 1.2× 104 1.0× 15 700
Mathilde Romagnoli France 15 361 0.9× 226 1.5× 48 0.3× 161 1.3× 81 0.8× 24 584
Rinat Keren United States 5 532 1.3× 327 2.1× 141 1.0× 160 1.3× 54 0.5× 5 763
Panagiotis Bouris Greece 11 288 0.7× 185 1.2× 197 1.4× 165 1.4× 47 0.5× 11 590
Kym L. Stanley Australia 9 588 1.4× 310 2.0× 146 1.0× 123 1.0× 107 1.1× 10 893
Ana Llorens Spain 8 372 0.9× 226 1.5× 91 0.6× 138 1.1× 52 0.5× 13 557
Carole Voland France 10 308 0.7× 202 1.3× 54 0.4× 125 1.0× 82 0.8× 11 564
Virginia Ladeda Argentina 11 345 0.8× 163 1.1× 166 1.2× 134 1.1× 58 0.6× 12 584
Graham Craggs United Kingdom 7 468 1.1× 126 0.8× 39 0.3× 114 0.9× 130 1.3× 8 650

Countries citing papers authored by Dunrui Wang

Since Specialization
Citations

This map shows the geographic impact of Dunrui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dunrui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dunrui Wang more than expected).

Fields of papers citing papers by Dunrui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dunrui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dunrui Wang. The network helps show where Dunrui Wang may publish in the future.

Co-authorship network of co-authors of Dunrui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dunrui Wang. A scholar is included among the top collaborators of Dunrui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dunrui Wang. Dunrui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuyi, Hidetaka Ohnuki, Andy D. Tran, et al.. (2025). Induced clustering of SHP2-depleted tumor cells in vascular islands restores sensitivity to MEK/ERK inhibition. Journal of Clinical Investigation. 135(10).
2.
Tripathi, Brajendra K., Xiaolan Qian, Marian E. Durkin, et al.. (2024). The pro-oncogenic noncanonical activity of a RAS•GTP:RanGAP1 complex facilitates nuclear protein export. Nature Cancer. 5(12). 1902–1918. 1 indexed citations
3.
Zhang, Tiantian, Sha Li, Xiang Chen, et al.. (2024). Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis. Cancer Letters. 604. 217240–217240.
4.
Wang, Dunrui, Xiaolan Qian, Yi‐Chieh Nancy Du, & Beatriz Sánchez‐Solana. (2023). cProSite: A Web Based Interactive Platform for Online Proteomics, Phosphoproteomics, and Genomics Data Analysis. PubMed. 6(4). 573–578. 18 indexed citations
5.
Feng, Jennifer, Xiang Chen, Dunrui Wang, et al.. (2021). High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer. Cancer Letters. 514. 79–89. 18 indexed citations
6.
Tripathi, Brajendra K., Xiaolan Qian, Dunrui Wang, et al.. (2021). Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein. Nature Communications. 12(1). 6941–6941. 12 indexed citations
7.
Wang, Yuyi, Ombretta Salvucci, Hidetaka Ohnuki, et al.. (2021). Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth. EMBO Molecular Medicine. 13(7). e14089–e14089. 20 indexed citations
8.
Sánchez‐Solana, Beatriz, Dunrui Wang, Xiaolan Qian, et al.. (2021). The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1. Molecular Cancer. 20(1). 141–141. 9 indexed citations
9.
Wang, Dunrui, Xiaolan Qian, Beatriz Sánchez‐Solana, et al.. (2020). Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function. Cancer Research. 80(17). 3568–3579. 15 indexed citations
10.
Tripathi, Brajendra K., Xiaolan Qian, Ming Zhou, et al.. (2019). SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions. The Journal of Cell Biology. 218(9). 3060–3076. 11 indexed citations
11.
Jin, Linchun, Dunrui Wang, Kristianna M. Fredenburg, et al.. (2018). CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma. Oral Oncology. 78. 145–150. 53 indexed citations
12.
Tripathi, Brajendra K., Xiaolan Qian, Ming Zhou, et al.. (2017). Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1. The Journal of Cell Biology. 216(12). 4255–4270. 30 indexed citations
13.
Ohnuki, Hidetaka, Kan Jiang, Dunrui Wang, et al.. (2014). Tumor-Infiltrating Myeloid Cells Activate Dll4/Notch/TGF-β Signaling to Drive Malignant Progression. Cancer Research. 74(7). 2038–2049. 34 indexed citations
14.
15.
Qian, Xiaolan, Marian E. Durkin, Dunrui Wang, et al.. (2012). Inactivation of the Dlc1 Gene Cooperates with Downregulation of p15INK4b and p16Ink4a , Leading to Neoplastic Transformation and Poor Prognosis in Human Cancer. Cancer Research. 72(22). 5900–5911. 25 indexed citations
16.
Wang, Dunrui, et al.. (2003). Studies characterizing 60 kda autoantibodies in subjects with schizophrenia. Biological Psychiatry. 53(5). 361–375. 23 indexed citations
17.
Wang, Dunrui, et al.. (2001). Leucine zipper domain of 52 kDa SS-A/Ro promotes protein dimer formation and inhibits in vitro transcription activity. Biochimica et Biophysica Acta (BBA) - General Subjects. 1568(2). 155–161. 19 indexed citations
18.
Wang, Dunrui, Jill P. Buyon, Wei‐Guo Zhu, & Edward K. L. Chan. (1999). Defining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies. Journal of Clinical Investigation. 104(9). 1265–1275. 33 indexed citations
19.
Wang, Dunrui, Jill P. Buyon, & Edward K. L. Chan. (1996). Cloning and expression of mouse 60 kDa ribonucleoprotein SS-A/Ro. Molecular Biology Reports. 23(3-4). 205–210. 22 indexed citations
20.
Wang, Dunrui & Edward K. L. Chan. (1996). 17-β-Estradiol Increases Expression of 52-kDa and 60-kDa SS-A/Ro Autoantigens in Human Keratinocytes and Breast Cancer Cell Line MCF-7. Journal of Investigative Dermatology. 107(4). 610–614. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morihiro Higo Breakdown of academic impact, for papers by Dong L. Barraclough Breakdown of academic impact, for papers by Mathilde Romagnoli Breakdown of academic impact, for papers by Rinat Keren Breakdown of academic impact, for papers by Panagiotis Bouris Breakdown of academic impact, for papers by Kym L. Stanley Breakdown of academic impact, for papers by Ana Llorens Breakdown of academic impact, for papers by Carole Voland Breakdown of academic impact, for papers by Virginia Ladeda Breakdown of academic impact, for papers by Graham Craggs
Rankless by CCL
2026